IDEXX Labs (NASDAQ: IDXX) reported Q4 EPS of $2.92, $0.01 worse than the analyst estimate of $2.93. Revenue for the quarter came in at $1.09 billion versus the consensus estimate of $1.07 billion.

GUIDANCE:

IDEXX Labs sees FY2026 EPS of $14.29-$14.80, versus the consensus of $14.54. IDEXX Labs sees FY2026 revenue of $4.63-4.72 billion, versus the consensus of $4.66 billion.

For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.